Typicality: | 0.452 |
Saliency: | 0.473 |
from the placebo | 4 | other |
with 72 patients | 3 | other |
with serological markers of inflammation | 3 | other |
colleague → evaluate → datum | 11 |
colleague → compare → datum | 10 |
colleague → assess → datum | 3 |
negative | neutral | positive |
0.090 | 0.819 | 0.091 |
Raw frequency | 24 |
Normalized frequency | 0.473 |
Modifier score | 0.500 |
Perplexity | 334.164 |